Clinical Trials Directory

Trials / Unknown

UnknownNCT04265729

Neocate In Infants and Children With Complex Conditions

An Open-label, Explorative, Post Launch Study of Neocate Amino Acid-based Feeds to Evaluate Nutritional Status and Gastrointestinal Tolerance in Infants and Children With Complex Conditions

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Nutricia Research · Industry
Sex
All
Age
10 Years
Healthy volunteers
Not accepted

Summary

Infants and young children up to 10 years of age with a complex condition involving the gastrointestinal tract are at risk of poor nutritional status, including faltering growth. Due to the complex condition, standard nutrition is often not tolerated and causes gastrointestinal symptoms. Formulas in which protein is replaced by its smallest elements, amino acids are easier for the body to digest and absorb. These formulas might be tolerated better and reduce gastrointestinal symptoms in infants and young children with complex conditions. The objectives of the present, exploratory study are to gain clinical evidence related to the nutritional status and gastrointestinal tolerance in infants and young children with complex conditions receiving Neocate as their primary source of nutrition. Additional objectives are to describe the nutritional and pharmacological management of these infants and young children. Study duration for each participant will be 52 weeks at maximum.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTNeocate Infant and Junior marketed productsuse of Neocate Infant and Junior marketed products

Timeline

Start date
2020-03-01
Primary completion
2021-07-01
Completion
2022-03-01
First posted
2020-02-12
Last updated
2020-02-12

Locations

4 sites across 3 countries: United States, Germany, United Kingdom

Source: ClinicalTrials.gov record NCT04265729. Inclusion in this directory is not an endorsement.